Ayaan Parikh
| Ayaan Parikh | |
| Occupation | Entrepreneur, co-founder and CEO of Convexia |
|---|---|
| Known for | Co-founding Convexia, an AI-driven pharmaceutical company |
| Education | Stanford University (Computer Science and Biology, enrolled 2024) |
| Website | convexia.bio |
Ayaan Parikh is an American entrepreneur and co-founder and CEO of Convexia, a pharmaceutical company that uses artificial intelligence agents to discover, evaluate, and develop drug assets. Convexia, which describes itself as "the world's first AI-maximalist pharma company,"[1] was part of Y Combinator's Summer 2025 batch.[2]
Early life and education
Parikh grew up in Wichita, Kansas, where he attended Wichita Collegiate School. While in high school, he was active in debate and scholars bowl competitions, and was a member of one of four Wichita Collegiate teams that shared the 2-speaker Class 3-1A debate championship.[3]
In 2022, at the age of 17, Parikh founded Medic All, a nonprofit organization that used telemedicine to increase healthcare access for low-income patients in the Wichita area. The nonprofit partnered with Wichita State University's physician assistant program and the Kansas College of Osteopathic Medicine to connect underserved patients with remote medical consultations.[4] In 2023, Medic All was selected as a finalist in a healthtech pilot competition, bringing Parikh regional recognition as a young social entrepreneur.[5]
After graduating high school in May 2024, Parikh was named CEO of Novus, a Wichita-based startup that tracks and rewards people during recovery from substance abuse.[6] He subsequently enrolled at Stanford University in the fall of 2024, where he is studying computer science and biology, before departing to focus on Convexia following its acceptance into Y Combinator.[7]
Career
Convexia
At Stanford, Parikh co-founded Convexia with Rahul Vijayan, a fellow student with whom he had previously co-founded three startups prior to Convexia, according to the company's Y Combinator profile.[8] The company was accepted into Y Combinator's Summer 2025 batch and officially debuted in July 2025.[9]
Convexia describes its model as an end-to-end AI stack for pharmaceutical development, deploying multiple autonomous agents across the drug development pipeline. Its Sourcing Agent scans public and private databases for overlooked preclinical drug candidates, including abandoned pharmaceutical intellectual property. A Scientific Evaluation Stack runs computational biology models—including tools such as ESM-3, RFdiffusion, Boltz-2, and AlphaFold—to assess drug safety and efficacy in silico. Additional agents analyze commercial viability, operational risk through digital twin simulations, and probability of clinical trial success. Human review by PhD-level scientists and key opinion leaders is incorporated at multiple stages before development decisions are made.[10] The company claims its approach enables drug development that is "10x faster and 20x leaner" than traditional pharmaceutical development methods.[11]
The use of AI agents in drug discovery—including autonomous systems for target identification, molecular generation, and clinical trial design—has become an active area of pharmaceutical research and investment in the mid-2020s. A peer-reviewed survey published in 2026 in the journal Drug Discovery Today catalogued applications and case studies of AI agents across the drug development lifecycle, reflecting the rapid pace at which autonomous machine learning systems are being integrated into preclinical and early clinical workflows.[12] Convexia's self-described "AI-maximalist" positioning reflects this broader industry trend. As of the company's July 2025 debut, Convexia was actively recruiting founding engineering talent to build out its autonomous agent infrastructure.[13]
References
- ↑ "Convexia – Y Combinator". 'Y Combinator}'. Retrieved 2026-03-19.
- ↑ "Convexia – Y Combinator". 'Y Combinator}'. Retrieved 2026-03-19.
- ↑ "State debate roundup: Quartet of Wichita Collegiate teams share 2-speaker Class 3-1A debate championship". 'KSHSAA Covered}'. Retrieved 2026-03-19.
- ↑ "Wichita Collegiate student starts nonprofit to bring health care to low-income people". 'KSN-TV}'. Retrieved 2026-03-19.
- ↑ "17-year-old social entrepreneur among finalists tapped for healthtech pilot competition". 'Startland News}'. Retrieved 2026-03-19.
- ↑ "Teen becomes CEO of Wichita startup company". 'KSN-TV}'. Retrieved 2026-03-19.
- ↑ "Convexia – Founder Trace". 'Founder Trace}'. Retrieved 2026-03-19.
- ↑ "Convexia – Y Combinator". 'Y Combinator}'. Retrieved 2026-03-19.
- ↑ "'AI-maximalist' pharma firm Convexia, backed by Y Combinator, officially debuts". 'The American Bazaar}'. Retrieved 2026-03-19.
- ↑ "Convexia – How Convexia Works". 'Convexia}'. Retrieved 2026-03-19.
- ↑ "'AI-maximalist' pharma firm Convexia, backed by Y Combinator, officially debuts". 'The American Bazaar}'. Retrieved 2026-03-19.
- ↑ "AI agents in drug discovery: applications and case studies". 'Drug Discovery Today, ScienceDirect}'. Retrieved 2026-03-19.
- ↑ "Founding Engineer at Convexia (Y Combinator)". 'Y Combinator}'. Retrieved 2026-03-19.